ABVX
Price
$113.32
Change
+$22.71 (+25.06%)
Updated
Feb 3 closing price
Capitalization
8.67B
47 days until earnings call
Intraday BUY SELL Signals
ANEB
Price
$0.95
Change
-$1.38 (-59.23%)
Updated
Feb 3 closing price
Capitalization
39.36M
2 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ABVX vs ANEB

Header iconABVX vs ANEB Comparison
Open Charts ABVX vs ANEBBanner chart's image
Abivax SA
Price$113.32
Change+$22.71 (+25.06%)
Volume$733.97K
Capitalization8.67B
Anebulo Pharmaceuticals
Price$0.95
Change-$1.38 (-59.23%)
Volume$70.69K
Capitalization39.36M
ABVX vs ANEB Comparison Chart in %
ABVX
Daily Signal:
Gain/Loss:
ANEB
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ABVX vs. ANEB commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABVX is a Hold and ANEB is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (ABVX: $113.32 vs. ANEB: $0.95)
Brand notoriety: ABVX and ANEB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABVX: 41% vs. ANEB: 80%
Market capitalization -- ABVX: $8.67B vs. ANEB: $39.36M
ABVX [@Biotechnology] is valued at $8.67B. ANEB’s [@Biotechnology] market capitalization is $39.36M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABVX’s FA Score shows that 0 FA rating(s) are green whileANEB’s FA Score has 1 green FA rating(s).

  • ABVX’s FA Score: 0 green, 5 red.
  • ANEB’s FA Score: 1 green, 4 red.
According to our system of comparison, ABVX is a better buy in the long-term than ANEB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABVX’s TA Score shows that 3 TA indicator(s) are bullish while ANEB’s TA Score has 5 bullish TA indicator(s).

  • ABVX’s TA Score: 3 bullish, 4 bearish.
  • ANEB’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, ANEB is a better buy in the short-term than ABVX.

Price Growth

ABVX (@Biotechnology) experienced а -4.69% price change this week, while ANEB (@Biotechnology) price change was +4.38% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.22%. For the same industry, the average monthly price growth was +3.03%, and the average quarterly price growth was +35.17%.

Reported Earning Dates

ABVX is expected to report earnings on Mar 23, 2026.

ANEB is expected to report earnings on Feb 06, 2026.

Industries' Descriptions

@Biotechnology (-4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABVX($8.67B) has a higher market cap than ANEB($39.4M). ANEB YTD gains are higher at: -5.941 vs. ABVX (-15.969). ANEB has higher annual earnings (EBITDA): -8.1M vs. ABVX (-170.04M). ABVX has more cash in the bank: 104M vs. ANEB (10.4M). ABVX (0) and ANEB (0) have equivalent revenues.
ABVXANEBABVX / ANEB
Capitalization8.67B39.4M22,010%
EBITDA-170.04M-8.1M2,099%
Gain YTD-15.969-5.941269%
P/E RatioN/AN/A-
Revenue00-
Total Cash104M10.4M1,000%
Total Debt92.6MN/A-
TECHNICAL ANALYSIS
Technical Analysis
ABVXANEB
RSI
ODDS (%)
Bearish Trend 7 days ago
71%
Bullish Trend 1 day ago
82%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
89%
Momentum
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
89%
MACD
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
78%
Bullish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 14 days ago
89%
Bullish Trend 6 days ago
82%
Declines
ODDS (%)
Bearish Trend 6 days ago
79%
Bearish Trend 1 day ago
86%
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
84%
Aroon
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ABVX
Daily Signal:
Gain/Loss:
ANEB
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SMDX24.200.36
+1.51%
Intech S&P Small-Mid Cap Diversified Alpha ETF
TIER29.860.02
+0.06%
T. Rowe Price International Equity Research ETF
FLGB35.66N/A
N/A
Franklin FTSE United Kingdom ETF
USEP39.51-0.13
-0.33%
Innovator US Equity Ultra Buffer ETF-Sep
SEMI30.82-0.78
-2.47%
Columbia Select Technology ETF

ABVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABVX has been loosely correlated with NEVPF. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if ABVX jumps, then NEVPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABVX
1D Price
Change %
ABVX100%
+1.67%
NEVPF - ABVX
65%
Loosely correlated
N/A
IMNN - ABVX
58%
Loosely correlated
N/A
ANEB - ABVX
49%
Loosely correlated
-0.75%
CGON - ABVX
38%
Loosely correlated
-3.28%
XENE - ABVX
38%
Loosely correlated
+1.62%
More

ANEB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANEB has been loosely correlated with ABVX. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ANEB jumps, then ABVX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANEB
1D Price
Change %
ANEB100%
-0.75%
ABVX - ANEB
49%
Loosely correlated
+1.67%
TECX - ANEB
28%
Poorly correlated
+1.87%
ALDX - ANEB
28%
Poorly correlated
-0.37%
IMNN - ANEB
26%
Poorly correlated
N/A
BCTX - ANEB
26%
Poorly correlated
-3.13%
More